Effects of betamethasone on inflammation and emphysema induced by cadmium nebulisation in rats

European Journal of Pharmacology

Volumn 606, Issue 1-3, 2009, Pages 210-214

  Fiévez, Laurence ^a   Kirschvink, Nathalie ^a   Zhang, Wenhui H ^b   Lagente, Vincent ^c   Lekeux, Pierre ^a   Bureau, Fabrice ^a   Gustin, Pascal ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b University Jia Tong   (China)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Cadmium; Emphysema; Glucocorticoid; Inflammation; MMP

Indexed keywords

BETAMETHASONE; CADMIUM; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; LUNG EMPHYSEMA; LUNG LAVAGE; MALE; MORPHOMETRICS; NEBULIZATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; TOBACCO;

EID: 61449252803     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.01.020     Document Type: Article

References (38)

1. Atkinson J.J., and Senior R.M. Matrix metalloproteinase-9 in lung remodelling. Am. J. Respir. Crit. Care Med. 28 (2003) 12-24
2. Baader E.W. Chronic cadmium poisoning. Industr. Med. Surg. 21 (1952) 427
3. Barnes P.J. New developments in chronic obstructive pulmonary disease. N. Engl. J. Med. 343 (2000) 269-280
4. Barnes P.J. Corticosteroid resistance in airway disease. Proc. Am. Thorac. Soc. 1 (2004) 264-268
5. Barnes P.J., Shapiro S.D., and Pauwels R.A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur. Respir. J. 22 (2003) 672-688
6. Belvisi M.G., and Bottomley K.M. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?. Inflamm. Res. 52 (2003) 95-100
7. Betsuyaku T., Nishimura M., Takeyabu K., Tanino M., Venge P., Xu S., and Kawagami Y. Neutrophil granule proteins in bronchoalveolar lavage fluid subjects with subclinical emphysema. Am. J. Respir. Crit. Care Med. 159 (1999) 1985-1991
8. Birrell M.A., Wong S., Hele D.J., McCluskie K., Hardaker E., and Belvisi M.G. Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-κB pathway activation. Am. J. Respir. Crit. Care Med. 172 (2005) 74-84
9. Cataldo D., Munaut C., Noel A., Frankenne F., Bartsch P., Foidart J.M., and Louis R. MMP-2 and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int. Arch. Allergy Immunol. 123 (2000) 259-267
10. Cataldo D.D., Gueders M.M., Rocks N., Sounni N.E., Evrard B., Bartsch P., Louis R., Noel A., and Foidart J.-M. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell. Mol. Biol. 49 (2003) 875-884
11. Choe K.H., Taraseviciene-Stewart L., Scerbavicius R., Gera L., Tuder R.M., and Voelkel N.F. Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. Am. J. Respir. Crit. Care Med. 167 (2003) 1516-1521
12. Culpitt S.V., Maziak W., Loukidis S., Nightingale J.A., Matthews J.L., and Barnes P.J. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160 (1999) 1635-1639
13. Davison A.G., Fayers P.M., Taylor A.J., Venables K.M., Darbyshire J., Pickering C.A., Chettle D.R., Franklin D., Guthrie C.J., Scott M.C., O'Malley D., Holden H., Mason H.J., Wright A.L., and Gompertz D. Cadmium fume inhalation and emphysema. Lancet 26 (1988) 663-667
14. Demedts I.K., Morel-Montero A., Lebecque S., Pacheco Y., Cataldo D., Joos G.F., Pauwelst R.A., and Brusselle G.G. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 61 (2006) 196-201
15. Gevenois P.A., De M.V., De V.P., Zanen J., and Yernault J.C. Pulmonary emphysema: quantitative CT during expiration. Radiology 199 (1996) 825-829
16. Hautamaki R.D., Kobayashi D.K., Senior R.M., and Shapiro S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277 (1997) 2002-2004
17. Hoshino M., Takahashi M., Takai Y., and Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J. Allergy Clin. Immunol. 104 (1999) 356-363
18. IRPTC legal file. Geneva: international register of potentially toxic chemicals. United Nations Environmental program, 1987 vol. 1 (1986)
19. Jarup L., Berglund M., Elinder C.G., Nordberg G., and Vahter M. Health effects of cadmium exposure: a review of the literature and a risk estimate. Scand. J. Work Environ. Health 24 (1998) 1-51
20. Kazantzis G., Flynn F.V., Spowage J.S., and Trott D.G. Renal tubular malfunction and pulmonary emphysema in cadmium pigment workers. Quart. J. Med. 32 (1963) 165-192
21. Keatings V.M., Jatakanon A., Worsdell Y.M., and Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 155 (1997) 542-548
22. Kirschvink N., Vincke G., Fievez L., Onclinx C., Wirth D., Belleflamme M., Louis R., Cataldo D., Peck M.J., and Gustin P. Repeated cadmium nebulisations induce pulmonary MMP-2 and MMP-9 production and emphysema in rats. Toxicology 211 (2005) 36-48
23. Lane R.G., and Campbell A.C.P. Fatal emphysema in two men making a copper-cadmium alloy. Br. J. Ind. Med. 11 (1954) 118-122
24. Mannino D.M., Holguin F., Greves H.M., Savage-Brown A., Stock A.L., and Jones R.L. Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey. Thorax 59 (2004) 194-198
25. Mao J.T., Tashkin D.P., Belloni P.N., Baileyhealey I., Baratelli F., and Roth M.D. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest 124 (2003) 1724-1732
26. Ohnishi K., Takagi M., Kurokawa Y., Satomi S., and Konttinen Y.T. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab. Invest. 78 (1998) 1077-1087
27. Oishi Y., Fu Z.W., Ohnuki Y., Kato H., and Noguchi T. Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases. Br. J. Dermatol. 147 (2002) 859-868
28. Princi F., and Geever E.F. Prolonged inhalation of cadmium. Arch. Ind. Hyg. Occup. Med. 1 (1950) 651-661
29. Pross C., Farooq M.M., Angle N., Lane J.S., Cerveira J.J., Xavier A.E., Freischlag J.A., Law R.E., and Gelabert H.A. Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity. J. Surg. Res. 102 (2002) 57-62
30. Russell R.E.K., Culpitt S.V., DeMatos C., Donnelly L., Smith M., Wiggins J., and Barnes P.J. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol. 26 (2002) 602-609
31. Shapiro S.D., Goldstein N.M., Houghton A.M.G., Kobayashi D.K., Kelley D., and Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol. 163 (2003) 2329-2335
32. Shull S., Meisler N., Absher M., Phan S., and Cutroneo K. Glucocorticoid-induced down regulation of transforming growth factor-beta 1 in adult rat lung fibroblasts. Lung 173 (1995) 71-78
33. Snider G.L., Hayes J.A., Korthy A.L., and Lewis G.P. Centrilobular emphysema experimentally induced by cadmium chloride aerosol. Am. Rev. Respir. Dis. 108 (1973) 40-48
34. Stetler-Stevenson W., Krutzsch H.C., and Liotta L.A. Tissue inhibitor of metalloproteinase (TIMP-2). J. Biol. Chem. 264 (1989) 17374-17378
35. Thurlbeck W.M., and Foley F.D. Experimental pulmonary emphysema: the effect of intra-tracheal injection of cadmium chloride solution in the guinea pig. Am. J. Pathol. 42 (1963) 431-441
36. Valencia A.M., Beharry K.D., Ang J.G., Devarajan K., Van Woerkom R., Abrantes M., Nishihara K., Chang E., Waltzman J., and Modanlou H.D. Early postnatal dexamethasone influences matrix metalloproteinase-2 and -9, and tissue inhibitors in the developing rat lung. Pediatr. Pulmonol. 35 (2003) 456-462
37. Vestbo J., Sorensen T., Lange P., Brix A., Torre P., and Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 353 (1999) 1819-1823
38. Xu L., Cai B.Q., and Zhu Y.J. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats. Chin. Med. J. (Engl.) 117 (2004) 1611-1619